SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-311593
Filing Date
2022-12-23
Accepted
2022-12-23 08:49:02
Documents
12
Period of Report
2022-12-22
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d440696d8k.htm   iXBRL 8-K 28744
  Complete submission text file 0001193125-22-311593.txt   152195

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acor-20221222.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20221222_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20221222_pre.xml EX-101.PRE 11260
6 EXTRACTED XBRL INSTANCE DOCUMENT d440696d8k_htm.xml XML 3402
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 221483447
SIC: 2836 Biological Products, (No Diagnostic Substances)